Because BRAF mutations are more frequent in mucinous carcinomas than in non-mucinous carcinomas as demonstrated by the present study and a previous study [63], the poor prognosis associated with mucinous histology may be at least partially explained by the poor prognosis of patients with CRC having BRAF mutations. The gene discussed is BRAF; the disease is mucinous adenocarcinoma.